Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

PeptiDream, Nihon Medi-Physics Plan Joint R&D for Simultaneous Diagnosis and Treatment of Cancer

Filed Under: Innovation, Pharma Tagged With: , , , , , ,

PeptiDream Inc. (TYO:4587) and Nihon Medi-Physics Co. Ltd. (NMP) announced on Dec. 18 that they intend to conduct joint efforts…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…
Tokyo Tech Works on New Form of Photodynamic Cancer Treatment
Tokyo Tech Works on New Form of Photodynamic Cancer…
Tokyo Tech Devises a New Generation of BPA for Use in Chemical Surgery
Tokyo Tech Devises a New Generation of BPA for Use in…
AGC Enters Medical Diagnosis Sector With Exosome Isolation Kits
AGC Enters Medical Diagnosis Sector With Exosome Isolation…
Tokyo Institute of Technology, Kanto Chemical Develop Growth Medium for iPS Cell-Derived Small Intestine Models
Tokyo Institute of Technology, Kanto Chemical Develop Growth…
Tosoh Enables Simple Removal of Regenerative Medicine Cells Using New Thermoresponsive Polymer
Tosoh Enables Simple Removal of Regenerative Medicine Cells…